295:
590:
24:
522:"Phase IIIB, Open-label, Multi-Center Study of the Efficacy and Safety of Rigosertib Administered as 72-hour Continuous Intravenous Infusions in Patients with Myelodysplastic Syndrome with Excess Blasts Progressing on or After Azacitidine or Decitabine"
107:
667:
657:
638:
334:
318:
InChI=1S/C21H25NO8S/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24/h5-11,22H,12-13H2,1-4H3,(H,23,24)/b8-7+
631:
662:
487:
624:
309:
444:
196:
412:
252:
273:
537:"Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent"
440:
436:
154:
147:
46:
36:
290:
604:
72:
451:
566:
608:
501:
174:
556:
548:
357:
82:
261:
601:
294:
127:
597:
561:
536:
406:
651:
241:
521:
552:
467:
589:
391:
186:
165:
570:
228:
23:
435:
as trade name) is a synthetic benzyl styryl sulfone in development by
138:
405:
Except where otherwise noted, data are given for materials in their
342:: COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)O
216:
118:
106:
95:
207:
278:
612:
458:)-ON 01910·Na has less cytotoxicity on cancer cells.
488:"physical and chemical data on chemispider website"
195:
240:
81:
668:Antineoplastic and immunomodulating drug stubs
632:
8:
639:
625:
293:
173:
15:
658:Antineoplastic and immunomodulating drugs
560:
260:
479:
339:
314:
289:
321:Key: OWBFCJROIKNMGD-BQYQJAHWSA-N
153:
146:
126:
7:
586:
584:
51:(2-Methoxy-5-{methyl}anilino)acetate
231:
215:
40:(2-Methoxy-5-{methyl}phenyl)glycine
611:. You can help Knowledge (XXG) by
14:
588:
375:
369:
22:
445:chronic myelomonocytic leukemia
409:(at 25 °C , 100 kPa).
384:
378:
363:
1:
553:10.1016/j.molcel.2017.09.012
684:
583:
663:Experimental cancer drugs
441:phase III clinical trials
403:
350:
330:
305:
65:
57:
45:
35:
30:
21:
502:"Onconova Therapeutics"
470:-destabilizing agent.
443:for the treatment of
437:Onconova Therapeutics
47:Systematic IUPAC name
439:. Rigosertib is in
399: g·mol
18:
452:geometrical isomer
431:sodium salt, with
413:Infobox references
16:
620:
619:
547:(1): 210–223.e6.
421:Chemical compound
419:
418:
274:CompTox Dashboard
108:Interactive image
675:
641:
634:
627:
602:immunomodulatory
592:
585:
575:
574:
564:
535:Jost, M (2017).
532:
526:
525:
518:
512:
511:
509:
508:
498:
492:
491:
484:
466:Rigosertib is a
398:
386:
380:
377:
371:
365:
358:Chemical formula
298:
297:
282:
280:
264:
244:
233:
219:
199:
177:
157:
150:
130:
110:
85:
26:
19:
683:
682:
678:
677:
676:
674:
673:
672:
648:
647:
646:
645:
581:
579:
578:
534:
533:
529:
524:. 29 June 2020.
520:
519:
515:
506:
504:
500:
499:
495:
486:
485:
481:
476:
464:
422:
415:
410:
396:
383:
374:
368:
360:
346:
343:
338:
337:
326:
323:
322:
319:
313:
312:
301:
283:
276:
267:
247:
234:
222:
202:
189:
180:
160:
133:
113:
99:
88:
75:
61:
53:
52:
41:
12:
11:
5:
681:
679:
671:
670:
665:
660:
650:
649:
644:
643:
636:
629:
621:
618:
617:
598:antineoplastic
593:
577:
576:
541:Molecular Cell
527:
513:
493:
478:
477:
475:
472:
463:
460:
420:
417:
416:
411:
407:standard state
404:
401:
400:
394:
388:
387:
381:
372:
366:
361:
356:
353:
352:
348:
347:
345:
344:
341:
333:
332:
331:
328:
327:
325:
324:
320:
317:
316:
308:
307:
306:
303:
302:
300:
299:
291:DTXSID30207984
286:
284:
272:
269:
268:
266:
265:
257:
255:
249:
248:
246:
245:
237:
235:
227:
224:
223:
221:
220:
212:
210:
204:
203:
201:
200:
192:
190:
185:
182:
181:
179:
178:
170:
168:
162:
161:
159:
158:
151:
143:
141:
135:
134:
132:
131:
123:
121:
115:
114:
112:
111:
102:
100:
93:
90:
89:
87:
86:
78:
76:
71:
68:
67:
63:
62:
59:
55:
54:
50:
49:
43:
42:
39:
33:
32:
28:
27:
13:
10:
9:
6:
4:
3:
2:
680:
669:
666:
664:
661:
659:
656:
655:
653:
642:
637:
635:
630:
628:
623:
622:
616:
614:
610:
607:article is a
606:
603:
599:
594:
591:
587:
582:
572:
568:
563:
558:
554:
550:
546:
542:
538:
531:
528:
523:
517:
514:
503:
497:
494:
489:
483:
480:
473:
471:
469:
461:
459:
457:
453:
448:
446:
442:
438:
434:
430:
426:
414:
408:
402:
395:
393:
390:
389:
362:
359:
355:
354:
349:
340:
336:
329:
315:
311:
304:
296:
292:
288:
287:
285:
275:
271:
270:
263:
259:
258:
256:
254:
251:
250:
243:
239:
238:
236:
230:
226:
225:
218:
214:
213:
211:
209:
206:
205:
198:
194:
193:
191:
188:
184:
183:
176:
172:
171:
169:
167:
164:
163:
156:
155:ChEMBL2013119
152:
149:
148:ChEMBL1241855
145:
144:
142:
140:
137:
136:
129:
125:
124:
122:
120:
117:
116:
109:
104:
103:
101:
97:
92:
91:
84:
80:
79:
77:
74:
70:
69:
64:
56:
48:
44:
38:
34:
29:
25:
20:
613:expanding it
595:
580:
544:
540:
530:
516:
505:. Retrieved
496:
482:
465:
455:
449:
432:
428:
424:
423:
128:CHEBI:145417
66:Identifiers
58:Other names
468:microtubule
351:Properties
83:592542-59-1
17:Rigosertib
652:Categories
507:2019-04-26
474:References
425:Rigosertib
392:Molar mass
262:67DOW7F9GL
187:IUPHAR/BPS
166:ChemSpider
94:3D model (
73:CAS Number
37:IUPAC name
462:Mechanism
571:28985505
429:ON-01910
60:ON-01910
562:5640507
433:Estybon
242:6918736
229:PubChem
175:5293927
105::
569:
559:
397:451.49
335:SMILES
217:D10154
139:ChEMBL
31:Names
596:This
310:InChI
119:ChEBI
96:JSmol
609:stub
605:drug
567:PMID
450:Its
253:UNII
208:KEGG
197:7833
600:or
557:PMC
549:doi
279:EPA
232:CID
654::
565:.
555:.
545:68
543:.
539:.
447:.
373:25
367:21
640:e
633:t
626:v
615:.
573:.
551::
510:.
490:.
456:Z
454:(
427:(
385:S
382:8
379:O
376:N
370:H
364:C
281:)
277:(
98:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
